Emily McGibbon
- Infectious Diseases top 10%
- Modeling and Simulation top 2%
- Epidemiology
- Oncology
- Hepatology top 10%
- Co-authors
- Mary HuynhGretchen Van WyeHiu Tai ChanDonald R. OlsonKatherine BornschlegelAnne D. FineSharon BalterSharon K. Greene
- Topics
- COVID-19 epidemiological studies (7 papers)SARS-CoV-2 and COVID-19 Research (5 papers)Hepatitis B Virus Studies (5 papers)
- Partner nations
- United States
In The Last Decade
Emily McGibbon
17 papers receiving 407 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 215
- Modeling and Simulation 132
- Epidemiology 107
- Oncology 84
- Hepatology 54
Countries citing papers authored by Emily McGibbon
This map shows the geographic impact of Emily McGibbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily McGibbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily McGibbon more than expected).
Fields of papers citing papers by Emily McGibbon
This network shows the impact of papers produced by Emily McGibbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily McGibbon. The network helps show where Emily McGibbon may publish in the future.
Co-authorship network of co-authors of Emily McGibbon
This figure shows the co-authorship network connecting the top 25 collaborators of Emily McGibbon. A scholar is included among the top collaborators of Emily McGibbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily McGibbon. Emily McGibbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 16 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 19 | |
| 7 | 19 | |
| 8 | 36 | |
| 9 | 124 | |
| 10 | 115 | |
| 11 | 3 | |
| 12 | 14 | |
| 13 | 11 | |
| 14 | 2 | |
| 15 | 5 | |
| 16 | 34 | |
| 17 | 5 |
About Emily McGibbon
Emily McGibbon is a scholar working on Modeling and Simulation, Hepatology and Infectious Diseases, having authored 17 papers that have together received 421 indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Modeling and Simulation (132 citations), Infectious Diseases (215 citations) and Hepatology (54 citations). Emily McGibbon has collaborated with scholars based in United States. Frequent co-authors include Mary Huynh, Gretchen Van Wye, Hiu Tai Chan, Donald R. Olson, Katherine Bornschlegel, Anne D. Fine, Sharon Balter, Sharon K. Greene, Katelynn Devinney and Wenhui Li. Their work appears in journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.